Oncoclinicas do Brasil (ONCO3) — Cash Flow Reinvestment Rate
Oncoclinicas do Brasil (ONCO3) has a Cash Flow Reinvestment Rate of 0.91x as of September 2025, reinvesting R$138.30 Million (capex R$52.99 Million plus investments R$-85.31 Million) from operating cash flow of R$151.75 Million. Explore reinvestment intensity of Oncoclinicas do Brasil to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Oncoclinicas do Brasil Cash Flow Reinvestment Rate (2013–2020)
Historical reinvestment intensity for Oncoclinicas do Brasil across 6 annual periods. Also explore ONCO3 current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Oncoclinicas do Brasil (2013–2020)
Year-by-year capital reinvestment analysis for Oncoclinicas do Brasil. For live market cap and broader valuation context, see ONCO3 market cap.
| Year | Reinvestment Rate | Total Reinvested (BRL) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 2.76x | R$268.98 Million | R$97.56 Million | R$204.80 Million | ▲ +35.4% |
| 2019 | 2.04x | R$197.73 Million | R$97.08 Million | R$190.19 Million | ▼ -67.0% |
| 2018 | 6.17x | R$239.70 Million | R$38.86 Million | R$238.45 Million | ▲ +2225.0% |
| 2017 | 0.27x | R$35.89 Million | R$135.26 Million | R$34.64 Million | ▼ -83.1% |
| 2014 | 1.57x | R$14.57 Million | R$9.29 Million | R$14.57 Million | ▼ -30.5% |
| 2013 | 2.26x | R$16.58 Million | R$7.34 Million | R$16.58 Million | — |